Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Intake of psychedelics increased range of beliefs of consciousness, meaning, purpose
A single psychedelic experience increased a range of non-physicalist beliefs, such as consciousness, meaning and purpose, researchers reported in the Journal of Psychopharmacology.
Common myths, misconceptions about asset protection may hold back your planning
As advisors to physicians throughout the U. S., we often learn what misconceptions physicians have regarding how to protect their assets from potential lawsuits. In this article, I hope to dispel some incorrect assumptions you may have.
Log in or Sign up for Free to view tailored content for your specialty!
Eisai submits supplemental application to FDA for traditional approval of Leqembi
The manufacturer of Leqembi announced it has submitted a supplemental Biologics License Application to the FDA to support the conversion of its recent accelerated approval to a traditional approval.
FDA rules sNDA for treatment of agitation related to dementia sufficient for review
The FDA has determined that the supplementary new drug application for brexpiprazole, a drug to treat agitation associated with Alzheimer’s dementia, is sufficiently complete to permit a substantive review, according to the manufacturers.
Occupational stress negatively associated with resilience, mental health in psych nurses
For psychiatric nurses in China, occupational stress was negatively associated with psychological resilience and state of mental health, according to a study published in BMC Psychiatry.
Quantitative test to measure neurofilament light chain validated
Quanterix Corp. announced the validation of a laboratory developed test to quantitatively measure neurofilament light chain in serum as an aid in the evaluation of those who may have neurodegenerative conditions.
Amyloid burden similar among those with Alzheimer's disease, Down syndrome
Amyloid positron emission tomography scan changes were similar between individuals with autosomal dominant Alzheimer’s disease and those with Down syndrome, researchers reported in The Lancet Neurology.
Positive topline results shown in clinical trial of adolescent ADHD treatment
A digital medicine company has revealed positive topline results of an expansionist study evaluating the efficacy and safety of a novel therapeutic device to treat adolescents with ADHD.
FDA grants accelerated approval for Alzheimer's treatment
The FDA has granted accelerated approval for Leqembi for the treatment of Alzheimer’s disease, making it the second approved Alzheimer’s treatment, the agency announced in a press release.
Mental health of med students worse during postgrad exams, rebounded after 6 months
The mental health of medical students in China was significantly worse during postgraduate entrance examinations compared with 6 months after, according to a study published in BMC Psychiatry.